Literature DB >> 25373119

A critical examination of studies on curcumin for depression.

Chittaranjan Andrade1.   

Abstract

Curcumin, an ingredient of turmeric, is widely available as a nutritional supplement. Curcumin has biological properties that suggest its use for a large number of health-related conditions, including depression. Curcumin is effective in animal models of depression. However, controlled clinical trials provide no convincing evidence that patients with major depressive illness fare better with different extracts of curcumin (dosed at 500-1,000 mg/d) than with placebo (or no treatment) after 5-8 weeks of monotherapy or antidepressant-augmentation therapy. At present, therefore, there is insufficient evidence to encourage depressed patients to consider curcumin as a possible alternative to standard antidepressant therapy. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373119     DOI: 10.4088/JCP.14f09489

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Curcumin protects against cerebral ischemia-reperfusion injury by activating JAK2/STAT3 signaling pathway in rats.

Authors:  Linlin Li; Haiyong Li; Mingming Li
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Role of Curcumin in the Management of Schizophrenia: A Narrative Review.

Authors:  Damodharan Dinakaran; Vanteemar S Sreeraj; Ganesan Venkatasubramanian
Journal:  Indian J Psychol Med       Date:  2021-09-13

Review 3.  Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.

Authors:  Tapan Behl; Rashita Makkar; Aayush Sehgal; Neelam Sharma; Sukhbir Singh; Mohammed Albratty; Asim Najmi; Abdulkarim M Meraya; Simona Gabriela Bungau
Journal:  Molecules       Date:  2022-08-04       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.